GESTIÓN EN SALUD PÚBLICA: Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

viernes, 6 de enero de 2023

Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)